THC

Tenet Healthcare (THC) closed down 1.17% to $269.13, underperforming the broader market. The hospital operator is expected to report earnings on October 29, 2026, with consensus estimates projecting EPS of $4.59 (24.05% growth) and revenue of $5.47 billion (3.34% growth).

The company holds a Zacks Rank #3 (Hold) with a Forward P/E of 12.95, in line with industry averages. The Medical-Hospital industry ranks in the bottom 20% of all industries.

Tenet Healthcare (THC) is receiving significant investor attention. The hospital operator has returned +3.9% over the past month, outperforming the S&P 500's +0.7%.

The company is expected to post earnings of $4.59 per share for the current quarter (+24.1% YoY) with fiscal year earnings estimates of $21.04 (+25.4% YoY). However, Tenet received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the broader market. The stock is trading at a discount to peers with a Value Style Score of A.

Tenet Healthcare (THC) is featured as a stock to watch with a #3 (Hold) Zacks Rank and an A-rated VGM Score. The company demonstrates strong growth potential with a Growth Style Score of B and forecasted year-over-year earnings growth of 25.4% for the current fiscal year. One analyst revised earnings estimates upward in the last 60 days, with the Zacks Consensus Estimate increasing to $21.04 per share.